High pancreatic-specific lipase after Cefovecin (Convenia) in cats

The FDA has received 23 reports of high pancreatic-specific lipase in cats after Cefovecin. That is 0.3% of all reports for this medicine, compared with 0.2% across reports for all cat medicines.

23Reports

70%Marked serious

17%Recovered

26%Died or euthanised

14 daysTypical onset

How soon it started

Same day

1 5.0%

1–2 days

2 10%

3–7 days

2 10%

1–4 weeks

9 45%

Over a month

6 30%

How the animals did

Recovered

4 17%

Still unwell when reported

5 22%

Died

2 8.7%

Euthanised

4 17%

Not known

8 35%

Problems reported at the same time

18 78%

13 57%

11 48%

10 43%

10 43%

9 39%

9 39%

9 39%

Age of the animals

Under 1 year

1–3 years

4–7 years

8–11 years

12+ years

About this medicine

Cefovecin a long-acting antibiotic injection.

Products with this ingredient include Convenia. The FDA hides brand names in its public data, so these reports cover every product with the same active ingredients.

Questions owners ask

Can Cefovecin cause high pancreatic-specific lipase in cats?: 23 reports link the two, but a report alone does not prove the medicine was the cause: other illnesses, other medicines or coincidence can be involved. Your vet can judge it for your animal.
How soon after a dose was it reported?: In half of the reports with dates, it started within 14 days of the first dose.
What should I do?: Don't give another dose until you've spoken to your vet, and keep the packaging so you can tell them the product and dose. Your vet can also report it to the FDA (or you can, through the manufacturer or FDA form 1932a).

All reported side effects of Cefovecin in cats · Medicines most reported with high pancreatic-specific lipase